Does folic acid supplementation prevent or promote colorectal cancer? Results from model-based predictions

Cancer Epidemiology Biomarkers and Prevention

Volumn 17, Issue 6, 2008, Pages 1360-1367

  Luebeck, E Georg ^a   Moolgavkar, Suresh H ^a   Liu, Amy Y ^b   Boynton, Alanna ^b   Ulrich, Cornelia M ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b Cancer Prevention Research Program   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID;

ARTICLE; CANCER INCIDENCE; CANCER PREVENTION; CANCER RISK; CARCINOGENESIS; CELL PROLIFERATION; COLORECTAL CANCER; HUMAN; MATHEMATICAL MODEL; MUTATION RATE; PREDICTION; PRIORITY JOURNAL; TUMOR PROMOTION; VITAMIN SUPPLEMENTATION;

COLORECTAL NEOPLASMS; DNA METHYLATION; DNA REPLICATION; FOLIC ACID; HUMANS; MODELS, STATISTICAL; MUTATION; RISK;

EID: 53349174518     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-07-2878     Document Type: Article

References (37)

1. Choi SW, Mason JB. Folate status: effects on pathways of colorectal carcinogenesis. J Nutr 2002;132:2413-8S.
2. Kim YI. Folate and colorectal cancer: an evidence-based critical review. Mol Nutr Food Res 2007;51:267-92.
3. Ulrich CM. Folate and cancer prevention: a closer look at a complex picture. Am J Clin Nutr 2007;86:271-3.
4. Larsson SC, Giovannucci E, Wolk A. Folate intake, MTHFR polymorphisms, and risk of esophageal, gastric, and pancreatic cancer: a meta-analysis. Gastroenterology 2006;131:1271-83.
5. Ulrich CM, Potter JD. Folate supplementation: too much of a good thing? Cancer Epidemiol Biomarkers Prev 2006;15:189-93.
6. Stolzenberg-Solomon RZ, Chang SC, Leitzmann MF, et al. Folate intake, alcohol use, and postmenopausal breast cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Am J Clin Nutr 2006;83:895-904.
7. Cole BF, Baron JA, Sandler RS, et al. Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA 2007;297:2351-9.
8. Ulrich CM, Potter JD. Folate and cancer-timing is everything. JAMA 2007;297:2408-9.
9. Weitman SD, Lark RH, Coney LR, et al. Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues. Cancer Res 1992;52:3396-401.
10. Hough CD, Cho KR, Zonderman AB, Schwartz DR, Morin PJ. Coordinately up-regulated genes in ovarian cancer. Cancer Res 2001;61:3869-76.
11. Gates SB, Mendelsohn LG, Shackelford KA, et al. Characterization of folate receptor from normal and neoplastic murine tissue: influence of dietary folate on folate receptor expression. Clin Cancer Res 1996;2:1135-41.
12. Farber S. Some observations on the effect of folic acid antagonists on acute leukemia and other forms of incurable cancer. Blood 1949;4:160-7.
13. Radimer K, Bindewald B, Hughes J, Ervin B, Swanson C, Picciano MF. Dietary supplement use by US adults: data from the National Health and Nutrition Examination Survey, 1999-2000. Am J Epidemiol 2004;160:339-49.
14. Cannon-Albright LA, Bishop DT, Samowitz W, DiSario JA, Lee R, Burt RW. Colonic polyps in an unselected population: prevalence, characteristics, and associations. Am J Gastroenterol 1994;89:827-31.
15. Rutter CM, Yu O, Miglioretti DL. A hierarchical non-homogenous Poisson model for meta-analysis of adenoma counts. Stat Med 2007;26:98-109.
16. Honein MA, Paulozzi LJ, Mathews TJ, Erickson JD, Wong LY. Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. JAMA 2001;285:2981-6.
17. Pfeiffer CM, Caudill SP, Gunter EW, Osterloh J, Sampson EJ. Biochemical indicators of B vitamin status in the US population after folic acid fortification: results from the National Health and Nutrition Examination Survey 1999-2000. Am J Clin Nutr 2005;82:442-50.
18. Kim YI. Will mandatory folic acid fortification prevent or promote cancer? Am J Clin Nutr 2004;80:1123-8.
19. Luebeck EG, Moolgavkar SH. Multistage carcinogenesis and the incidence of colorectal cancer. Proc Natl Acad Sci U S A 2002;99:15095-100.
20. Hazelton WD, Luebeck EG, Heidenreich WF, Moolgavkar SH. Analysis of a historical cohort of Chinese tin miners with arsenic, radon, cigarette smoke, and pipe smoke exposures using the biologically based two-stage clonal expansion model. Radiat Res 2001;156:78-94.
21. Little MP, Haylock RG, Muirhead CR. Modelling lung tumour risk in radon-exposed uranium miners using generalizations of the two-mutation model of Moolgavkar, Venzon and Knudson. Int J Radiat Biol 2002;78:49-68.
22. van de Wetering M, Sancho E, Verweij C, et al. The β-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 2002;111:241-50.
23. Batlle E, Henderson JT, Beghtel H, et al. β-catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB/ephrinB. Cell 2002;111:251-63.
24. Meza R, Luebeck EG, Moolgavkar SH. Gestational mutations and carcinogenesis. Math Biosci 2005;197:188-210.
25. Ulrich C. Genetic variability in folate-mediated one-carbon metabolism and cancer risk. In: Choi SW, Friso S, editors. Nutrient-Gene Interactions in Cancer. Boca Raton (FL): Taylor & Francis Group; 2006. p. 75-91.
26. Ulrich CM. Nutrigenetics in cancer research-folate metabolism and colorectal cancer. J Nutr 2005;135:2698-702.
27. Mason JB, Dickstein A, Jacques PF, et al. A temporal association between folic acid fortification and an increase in colorectal cancer rates may be illuminating important biological principles: a hypothesis. Cancer Epidemiol Biomarkers Prev 2007;16:1325-9.
28. Melnyk S, Pogribna M, Miller BJ, Basnakian AG, Pogribny IP, James SJ. Uracil misincorporation, DNA strand breaks, and gene amplification are associated with tumorigenic cell transformation in folate deficient/repleted Chinese hamster ovary cells. Cancer Lett 1999;146:35-44.
29. Khosraviani K, Weir HP, Hamilton P, Moorehead J, Williamson K. Effect of folate supplementation on mucosal cell proliferation in high risk patients for colon cancer. Gut 2002;51:195-9.
30. Ulrich CM, Curtin K, Samowitz W, et al. MTHFR variants reduce the risk of G:C->A:T transition mutations within the p53 tumor suppressor gene in colon tumors. J Nutr 2005;135:2462-7.
31. Bach SP, Renehan AG, Potten CS. Stem cells: the intestinal stem cell as a paradigm. Carcinogenesis 2000;21:469-76.
32. Potten CS, Booth C, Tudor GL, et al. Identification of a putative intestinal stem cell and early lineage marker; musashi-1. Differentiation 2003;71:28-41.
33. Yatabe Y, Tavare S, Shibata D. Investigating stem cells in human colon by using methylation patterns. Proc Natl Acad Sci U S A 2001;98:10839-44.
34. American Cancer Society. Colorectal Cancer Facts and Figures Special Edition 2005. Atlanta: American Cancer Society, 2005.
35. Parzen E. Stochastic Processes: Society for Industrial and Applied Mathematics, 1999.
36. Heidenreich WF, Luebeck EG, Moolgavkar SH. Some properties of the hazard function of the two-mutation clonal expansion model. Risk Analysis 1997;17:391-9.
37. Hanin LG, Yakovlev A. A nonidentifiability aspects of the two-stage model of carcinogenesis. Risk Analysis 1986;16:711-5.